strokeTrasylol: Blood-Clotting Drug Tied to Kidney Damage, Heart Attack, and Stroke

Trasylol, the drug designed to reduce bleeding during heart bypass surgery, was recalled in 2007 after medical researchers found the drug increased the risk of kidney damage, heart attack, stroke, and death more than similar drugs. First approved by the Food and Drug Administration in 1993, Trasylol helped prevent life-threatening bleeding during cardiac and bypass surgeries by helping the blood clot faster, thus reducing the need for blood transfusions.

Continue →